Surreal illustration of kidney protein modification.

Protein Carbamylation: Is This Silent Threat Accelerating Kidney Disease?

Theo Raines in Health & Wellness November 2025 • 3 min read.

"Unraveling the link between protein modification and kidney disease mortality, and what you can do about it."

Chronic Kidney Disease (CKD) continues to be a major public health challenge. In 2018, over 700,000 people in the US alone were affected, with approximately 500,000 relying on regular dialysis to stay alive. Unfortunately, those with ESRD (End-Stage Renal Disease) face a significantly elevated risk of death, with cardiovascular issues being a primary concern. This risk is 10 to 30 times higher compared to individuals with healthy kidney function.

While traditional risk factors like hypertension and atherosclerosis are prevalent in ESRD, conventional treatments haven’t fully addressed the problem, suggesting that there are some unknown factors at play. New research is pointing toward a process called protein carbamylation as a key contributor.

Protein carbamylation is a type of protein modification that occurs when proteins are exposed to cyanate, a compound derived from urea. Although urea is usually found in small amounts in the body, it increases with declining kidney function. It's also been shown that free amino acids and myeloperoxidase enzyme play role in this process. This modification can change a protein's structure and function, leading to a cascade of negative effects at the molecular and cellular levels, eventually contributing to cardiovascular complications and other health problems.

How Carbamylation Affects Your Body

Surreal illustration of kidney protein modification.

The carbamylation reaction essentially involves adding a carbamoyl group to proteins. This seemingly small change neutralizes positive charges, disrupting the way proteins interact with water. As a result, protein structure can be compromised, leading to functional changes. Research has linked carbamylation to:

Carbamylation isn't solely tied to kidney disease. Studies have found it plays a role in a variety of other diseases such as cataract formation, arthritis and autoimmune diseases, and neurological diseases.

Accelerated Atherosclerosis: Contributing to the buildup of plaque in arteries.
Vascular Calcification: Hardening of blood vessels.
Erythropoiesis Dysfunction: Disrupting the production of red blood cells.

Because urea, cyanate and carbamylation naturally increase when kidney function declines, Nephrology research is of greater interest. Below are cardiovascular disease and erythropoietin resistance mechanisms carbamylation's link to it:

The Future of Carbamylation Research

The studies covered here show that lowering urea levels and restoring amino acid balance can reduce carbamylation burden. Nutritional and dialysis interventions are effective. More research is needed to understand the complex uremic environment and determine whether these interventions will lead to significant clinical impacts.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

Everything You Need To Know

What exactly is protein carbamylation?

Protein carbamylation is a protein modification process. It happens when proteins are exposed to cyanate, a compound derived from urea. When kidney function declines, urea levels increase, leading to higher cyanate levels and thus more protein carbamylation. Free amino acids and myeloperoxidase enzyme also contribute to this process.

Why is protein carbamylation considered a significant health concern, especially in the context of kidney disease?

Protein carbamylation is significant because it can change the structure and function of proteins in the body. This modification can lead to accelerated atherosclerosis (plaque buildup in arteries), vascular calcification (hardening of blood vessels), and erythropoiesis dysfunction (disrupted red blood cell production). These complications increase the risk of cardiovascular issues and other health problems, especially for individuals with chronic kidney disease.

How does carbamylation affect proteins and what are the implications of these changes?

The carbamylation reaction involves adding a carbamoyl group to proteins, neutralizing their positive charges and disrupting their interaction with water. This seemingly small change can compromise protein structure and function. It plays a role in diseases such as cataract formation, arthritis and autoimmune diseases, and neurological diseases. By understanding the molecular mechanisms of carbamylation, researchers hope to find ways to mitigate its negative effects and improve health outcomes.

Are there any ways to reduce or manage protein carbamylation?

Research indicates that lowering urea levels and restoring amino acid balance can reduce the burden of protein carbamylation. Nutritional and dialysis interventions have shown some effectiveness in achieving this. However, it is important to note that further research is needed to fully understand the complex uremic environment and determine whether these interventions will lead to significant clinical improvements.

Is protein carbamylation only related to kidney disease?

While protein carbamylation is linked to kidney disease, it is not solely tied to it. Studies have found it also plays a role in a variety of other diseases such as cataract formation, arthritis and autoimmune diseases, and neurological diseases. This suggests that the mechanisms involved in protein carbamylation may have broader implications for overall health and disease processes.